- Tumor Antigen Reactivity Plays Important Role in TIL Therapy Efficacy
- First-time Production of an Artificial Human Platelet Lysate
- Andelyn’s Platform Used to Manufacture Clinical Grade Viral Vector
- AI Designed DNA Sequences Modulate Cell Differentiation for Gene Therapy Applications
- In Vivo Bioprinting Shows Promise for 3D Printed Implants Without Surgery
Search results
-
H
The Best Games for May 2025
It’s time once again to take a look at the best games heading your way in the coming weeks, and while May is looking a little quieter than the past few months, it’s fair for the industry to take a break after the year it’s had so far. “Quieter” doesn’t mean “empty”, however, and if [...] The... -
H
StockWatch: Tools Giants Foresee Revenue Impacts from Tariffs, Job Cuts
Looming tariffs and recent job cuts from Washington have impacted two of the largest biotech tools companies that released first-quarter results this past week, prompting one to lower its earnings guidance to investors for the rest of 2025, while the other is maintaining its revenue forecast... -
H
Genomic Surveillance Platform Detects Hospital Infection Outbreaks, Saves Lives, Cuts Costs
University of Pittsburgh scientists working with UPMC infection preventionists have developed an infectious diseases detection platform that, over a two-year trial, was found to stop outbreaks, save lives, and cut costs. The Enhanced Detection System for Healthcare-Associated Transmission... -
H
BioSkryb and Tecan Introduce Single-Cell Multiomics Workflow
BioSkryb Genomics and Tecan report that they have introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME whole genome and transcriptome single-cell core kit with the Uno Single Cell Dispenser, provided by Tecan. The integrated solution enables... -
H
Sugar Swap Leads to Sweet Spot in Creating “Super Stem Cells”
A small shift in nutrient supply has led to the development of a new method to rejuvenate stem cells. Scientists at the University of Copenhagen found that these “super stem cells” remain healthier in culture and demonstrate an improved ability to differentiate into various specialized cell... -
H
New Podcast, The ImmunoVerse, Highlights Immunotherapy Research
From T cells to tumor takedowns, The ImmunoVerse podcast from the Moffitt Cancer Center is igniting a conversation around the visionaries and breakthroughs transforming how we treat cancer. A tumor immunologist and physician-scientist by training, Patrick Hwu, MD, president and CEO of the... -
H
Blocking Erythropoietin Signaling Renders Mouse Liver Tumors Sensitive to Anti-PD-1 Therapy
Stanford University scientists have found that erythropoietin (EPO), a protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells, also plays a surprising, critical role in dampening the immune system’s response to cancer. Their preclinical studies... -
H
AACR 2025: Professional Awards Acknowledge Contributions to Cancer Research and Treatment
Ahead of this year’s meeting of the American Association for Cancer Research (AACR), the organization has released the names of the recipients of several professional awards that are given out annually. These awards recognize outstanding accomplishments and achievements in cancer research... -
H
Revvity to Unveil VivoJect Image-guided Injection System at AACR
Revvity reports that it will unveil the VivoJect image-guided injection system at the AACR Annual Meeting in Chicago later this week. Paired with the Vega automated preclinical ultrasound system, the VivoJect system was designed for real-time imaging and precise operation. It streamlines in vivo... -
H
Immunai and Parker Institute to Build Massive Cancer Single-Cell Dataset
Immunai, an AI biotech company specializing in mapping the human immune system, and the Parker Institute for Cancer Immunotherapy (PICI), a San Francisco-based nonprofit organization that unites leading immuno-oncology experts from cancer centers across the United States, have announced a new... -
H
FUJIFILM Diosynth Biotechnologies and Regeneron Sign 10-year, $3+ Billion U.S. Manufacturing Deal
FUJIFILM Diosynth Biotechnologies signed a 10-year manufacturing supply agreement, valued at over $3 billion, with Regeneron Pharmaceuticals to provide U.S.-based production of its biologic medicines. FUJIFILM will provide U.S.-based manufacturing for Regeneron over the 10-year period through... -
H
Bioprinting Technique Brings Vascularized Tissue One Step Closer
Researchers at Carnegie Mellon University report that they have built a first-of-its-kind microphysiologic system, or tissue model, entirely out of collagen using their Freeform Reversible Embedding of Suspended Hydrogels (FRESH) 3D bioprinting technique. They say this advancement expands the... -
H
Signal Alert: Startup Seeks Community Funders for AAV Immuno-Gene Therapy
Nicole K. Paulk, PhD, CEO, founder, and president, Siren Biotechnology A startup committed to developing the world’s first universal adeno-associated viral (AAV) vector-based gene therapy for solid tumor cancers, with an initial focus on brain cancers, is borrowing a successful high-tech... -
H
Multi-Platform Sequencing Study of Four Generations Sheds Light on Mutation Rates
Using sequencing instruments from multiple vendors, scientists from the University of Utah Health, the University of Washington, PacBio, and elsewhere have developed what they claim is the most comprehensive atlas of genetic change through familial generations. Among other details, their... -
H
Psychedelics May Reverse Effects of Neuroimmune Interactions That Drive Fear Responses
A newly reported study suggests that fear and the immune system are connected in previously unknown ways. Results from the preclinical research, headed by scientists at Mass General Brigham, showed that interactions between immune and brain cells drive fear responses, and suggest that treatment... -
H
Watchmaker Genomics and Revvity Team to Automate and Streamline NGS Library Preparation
Watchmaker Genomics says it will collaborate with Revvity to automate and verify methods for all of its DNA and RNA library preparation kits on the Sciclone G3 NGSx liquid handling workstation. The agreement makes Revvity the first provider to automate Watchmaker’s entire library preparation... -
H
Novel Leukemia Target Found in RNA-Binding Cell Surface Protein
In 2021, the lab of chemical biologist and Nobel Laureate Carolyn Bertozzi, PhD, professor at Stanford University, characterized a new type of cell-surface protein, termed glycoRNAs, that form highly organized clusters with RNA-binding proteins to regulate communication between cells and their... -
H
Roche Commits $50B to U.S. Manufacturing, R&D as Tariffs Loom
With tariffs looming over biopharma, Roche became the latest industry giant to announce large-scale plans for new U.S. drug and diagnostic manufacturing operations, committing $50 billion over the next five years to the purpose. Roche projected that its $50 billion manufacturing investment, to... -
H
Panome Bio Adds Global Phosphoproteomics to its Portfolio of Multi-Omic Discovery Solutions
Multi-omics service company Panome Bio launched its global phosphoproteomics platform, which has been created to analyze both protein abundance and protein phosphorylation events, a key regulatory mechanism in virtually all biological processes. The company’s phosphoproteomics capabilities... -
H
Mount Sinai Team Finds New Way Cells Control RNA
Researchers at the Icahn School of Medicine at Mount Sinai say they have made a new discovery about how human cells make RNA, a molecule that functions as a set of blueprints that tell cells how to build proteins, which help bodies grow and stay healthy. But before RNA can do its job, it has to...